Accordingly, in an immunocompetent tumor microenvironment, IL-12/15/18 pre-activated NK cells might be superior in competing for low amounts of IL-2 with CD25+ regulatory T cells, which restrain IL-2–dependent expansion of NK cells and T cells after adoptive cell transfer (45, 46). Here, IL2 is linked to neoplasm.